Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT03492489 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03492489
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.